Listen Now

Where do you see yourself in 10 years? The ACCP Resident Advisory Committee assembled a panel representing four career paths and advice on how to get there. This podcast focuses on career advice for the early practitioner. Moderated by Henry Okoroike, guests include: Deborah Bondi, Elias Chahine, Christina Doligalski, and Alexander Flannery. 0:00 – 8:08   Can you share some advice that made a positive impact on you early on in your career? 8:08 – 16:12  What advice do you have for trainees about continuing to be a well-rounded clinical pharmacist? 16:12 – 18:33 What is your advice for new graduates and clinicians desiring to get involved in research and publishing? 18:33 – 22:50 What additional advice do you have on work/life balance? Whether you are about to begin your postgraduate training or finishing it, you are certain to find some helpful advice. Watch the full video: https://www.accp.com/resandfel/advice.aspx.

Where do you see yourself in 10 years? The ACCP Resident Advisory Committee assembled a panel representing four career paths and advice on how to get there. This podcast focuses on how involvement in ACCP contributed to the panelists professional development. Moderated by Henry Okoroike, guests include: Deborah Bondi, Elias Chahine, Christina Doligalski, and Alexander Flannery. 0:00 – 5:58   Describe how you first became involved with ACCP. 5:58 – 10:10  How has your involvement in ACCP affected or directed your career path? 10:10 – 17:47 What was your path to becoming a fellow of ACCP (FCCP)? 17:47 – 24:05 What contribution to ACCP or clinical pharmacy are you the most proud of? Whether you are about to begin your postgraduate training or finishing it, you are certain to find some helpful advice. Watch the full video: https://www.accp.com/resandfel/advice.aspx.

Co-founder and CEO of Your Financial Pharmacist, Tim Ulbrich, discusses financial wellness for postgraduate trainees. He offers advice on debt management, investing, and protecting your income now and throughout your career. 

Dr. Jerry L. Bauman, JACCP Editor-in-Chief, discusses key factors for designing, completing, and publishing retrospective research, like chart reviews. Full text of the manuscript is available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.1064. 

Dr. Daniel Longyhore discusses the importance of postgraduate trainees disseminating their research. 

Hopefully you matched in Phase 1, but what do you need to know about Phase 2 just in case? Learn from a colleague who has been through it. 

Ten minutes of tips for presenting an effective virtual poster.

Dr. Autumn Walkerly provides an overview of Spravato (esketamine) nasal spray for treatment resistant depression. References: Gaynes BN, Lux L, Gartlehner G, et al. Defining treatment-resistant depression. Depress Anxiety. 2020;37(2):134-45. Irwin MN, VandenBerg A. Retracing our steps to understand ketamine in depression: A focused review of hypothesized mechanisms of action. Ment Health Clin. 2021;11(3):200-10. Rush AJ, Trivedi MH, Wisniewski SR, et al. "Acute and longer-term outcomes in depressed outpatient requiring one or several treatment steps: A STAR*D report". Am J Psychiatry. 2006. 163(11):1905-17. Daly EJ, Trivedi MH, Janik A, et al. Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry. 2019;76(9):893-903. Fu DJ, Ionescu DF, Li X, et al. Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: double-blind, randomized study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191. Popova V, Daly EJ, Trivedi M, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. Am J Psychiatry. 2019;176(6):428-38.

Dr. Aaron Devanathan provides perspective on advancing your research career via the fellowship or Ph.D. route.  References: Bauman JL, Evans WE. Pharm.D.-only Investigators Are Critical to the Profession: Let’s Preserve the Fellowship as an Equally Important Way to Prepare Future Clinical Pharmaceutical Scientists: Or the Case Against the “All-Ph.D.” Pharmacotherapy. 2009 February;29(2):129–133. https://doi.org/10.1592/phco.29.2.129. O’Donnell JM, Anand S, Brown SD, et al. Report of the 2018-2019 Research and Graduate Affairs Committee. Am J of Pharm Ed. 2019;83(10):Article 7595. Assemi M, Suchanek Hudmon K, Sowinski KM, Corelli RL. Educational Background and Academic Rank of Faculty Members within US Schools of Pharmacy. Am J of Pharm Ed. 2016;80(4):Article 61. Morbitzer KA, McLaughlin JE, Devanathan AS, et al. How-to guide for overcoming barriers of research and scholarship training in Pharm.D. and pharmacy residency programs. J Am Coll Clin Pharm. 2021;1-11. https://doi.org/10.1002/jac5.1426.

ACCP Podcast for Residents by Residents: Dr. Monica Xi discusses careers in academia for residency trained pharmacists with Dr. Jeremy Daniel, Pharm.D., BCPS, BCPP, associate professor at South Dakota State University College of Pharmacy and Allied Health Professions.  Reference: Young S, Vos SS, Cantrell M, Shaw R. Factors associated with students' perception of preceptor excellence. Am J Pharm Educ. 2014 Apr 17;78(3):53. doi: 10.5688/ajpe78353.

Episode 44: ACCP Podcast for Residents by Residents: PAD; management of pain, agitation, and delirium in COVID-19 patients References: Adams CD, Altshuler J, Barlow BL, et al. Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID-19. Pharmacotherapy 2020;40(12):1180–1191. doi: 10.1002/phar.2471. Devlin JW, O’Neal Jr. HR, Thomas C, et al. Strategies to Optimize ICU Liberation (A to F) Bundle Performance in Critically Ill Adults With Coronavirus Disease 2019. Crit Care Expl 2020; 2:e0139. DOI: 10.1097/CCE.0000000000000139. Devlin JW, Skrobik Y, Gelinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med 2018;46(9):e825-73. DOI: 10.1097/CCM.0000000000003299. Alhazzani W, Evans L, Alshami F, et al. Surviving Sepsis Campaign Guidelines on the Management of Adults with Coronavirus Disease 2019 (COVID-19) in the ICU. Crit Care Med 2021;49(3):e219-34. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Moss M, Huang DT, Brower RG, et al. "Early neuromuscular blockade in the acute respiratory distress syndrome". N Engl J Med. 2019. 380(21):1997-2008. Papazian L, Forel J, Gacouin A, et al. "Neuromuscular blockers in early acute respiratory distress syndrome". N Engl J Med. 2010. 363(12):1107-1116.

Episode 43: ACCP Podcast for Residents by Residents: Answers to so many questions about board certification

'hhawbq8c' Episode 42: ACCP Podcast for Residents by Residents: Use of Oral Antibiotic Agents for Gram Negative Bacteremias

Episode 41: ACCP Podcast for Residents by Residents: SGLT2 Inhibitors and Heart Failure

Episode 40: ACCP Podcast for Residents by Residents: Antimicrobial Telestewardship

Episode 39: ACCP Podcast for Residents by Residents: ECMO and Toxicology

Episode 38: ACCP Podcast for Residents by Residents: Wellness and Burnout

Episode 37: ACCP Podcast for Residents by Residents: Transitioning into Residency.

Episode 35: ACCP Podcast for Residents by Residents: Andexanet.

Episode 35: ACCP Podcast for Residents by Residents: Paving your way in Ambulatory Care